At Shockwave, innovation is in our DNA. We never settle for the status quo and are constantly pioneering ways to address unmet clinical needs with low-risk treatment options for underserved patient populations suffering from cardiovascular disease. From Intravascular Lithotripsy (IVL) to Coronary Sinus Reduction and beyond, our technologies transform lives around the world.
As part of Johnson & Johnson MedTech, we’ll continue to deliver our same unmatched commitment to innovation, customer service and improving patient outcomes. In fact, the added strength of the global leader in healthcare energizes our ability to make even bigger waves – and the future looks shockingly bright.
Commitment beyond compare, with leaders dedicated to their teams. Meet the Shockwave leadership team.
Ready to help us disrupt the status quo and improve the lives of patients across the globe?